Showing results (1931-1940 of 9,628) with videos related to
Sort By:
Pageof 963
Leukemia|January 8, 2020
Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemiaHong He, Yukio Kondo, Ken Ishiyama, et al.Leukemia|March 24, 2020
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trialsO Al-Sawaf, S Robrecht, J Bahlo, et al.Leukemia|March 24, 2020
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort studySimon Husby, Francesco Favero, Christian Nielsen, et al.Leukemia|March 28, 2020
SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disordersAlexander Kaiser, Martin Schmidt, Otmar Huber, et al.Leukemia|October 22, 2020
CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemiaMariela Sivina, Lianchun Xiao, Ekaterina Kim, et al.Leukemia|October 21, 2020
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapyEva M Weissinger, Jochen Metzger, Michael Schleuning, et al.Leukemia|January 18, 2019
Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndromeFlavia Ribezzo, Inge A M Snoeren, Susanne Ziegler, et al.Leukemia|January 18, 2019
Targeting FLT3 mutations in AML: review of current knowledge and evidenceNaval Daver, Richard F Schlenk, Nigel H Russell, et al.Leukemia|April 1, 1987
Effect of alpha 2-interferon on hairy cells and cell lines: a role for type I interferon receptors and RNA synthesisJ D Schwarzmeier, M Schwabe, L Wagner, et al.Leukemia|February 10, 2019
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyKrzysztof Mrózek, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.Pageof 963